What is the equity of Kobayashi Pharmaceutical Co this year?
Kobayashi Pharmaceutical Co has equity of 204.82 B JPY this year.
Kobayashi Pharmaceutical Co Equity 2024
Kobayashi Pharmaceutical Co Equity
204.82 B JPY
Ticker
4967.T
ISIN
JP3301100008
WKN
920477
In 2024, Kobayashi Pharmaceutical Co's equity was 204.82 B JPY, a 3.49% increase from the 197.9 B JPY equity in the previous year.
Kobayashi Pharmaceutical Co Aktienanalyse
What does Kobayashi Pharmaceutical Co do?
Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Kobayashi Pharmaceutical Co's Equity
Kobayashi Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Kobayashi Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Kobayashi Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Kobayashi Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Kobayashi Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Kobayashi Pharmaceutical Co stock
What was the equity of Kobayashi Pharmaceutical Co compared to the previous year?
The equity of Kobayashi Pharmaceutical Co has increased/decreased by 3.49% increased compared to the previous year.
What impact does a high equity have on investors of Kobayashi Pharmaceutical Co?
A high equity is advantageous for investors of Kobayashi Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Kobayashi Pharmaceutical Co?
A low equity can be a risk for investors of Kobayashi Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Kobayashi Pharmaceutical Co affect the company?
An increase in equity of Kobayashi Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Kobayashi Pharmaceutical Co affect the company?
A reduction in equity of Kobayashi Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Kobayashi Pharmaceutical Co?
Some factors that can affect the equity of Kobayashi Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Kobayashi Pharmaceutical Co so important for investors?
The equity of Kobayashi Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Kobayashi Pharmaceutical Co take to change the equity?
To change equity, Kobayashi Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Kobayashi Pharmaceutical Co pay?
Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.
What is the dividend yield of Kobayashi Pharmaceutical Co?
The current dividend yield of Kobayashi Pharmaceutical Co is 1.84 %.
When does Kobayashi Pharmaceutical Co pay dividends?
Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.
How secure is the dividend of Kobayashi Pharmaceutical Co?
Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.
What is the dividend of Kobayashi Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 1.96 %.
In which sector is Kobayashi Pharmaceutical Co located?
Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
When did Kobayashi Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 3/1/2025.
What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?
In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.
In which currency does Kobayashi Pharmaceutical Co pay out the dividend?
The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Kobayashi Pharmaceutical Co
Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Kobayashi Pharmaceutical Co Revenue
- Kobayashi Pharmaceutical Co Net Income
- Kobayashi Pharmaceutical Co P/E
- Kobayashi Pharmaceutical Co P/S
- Kobayashi Pharmaceutical Co EBIT
- Kobayashi Pharmaceutical Co Dividend
- Kobayashi Pharmaceutical Co Stocks
- Kobayashi Pharmaceutical Co Market capitalization
- Kobayashi Pharmaceutical Co Debt
- Kobayashi Pharmaceutical Co Liabilities
- Kobayashi Pharmaceutical Co Equity
- Kobayashi Pharmaceutical Co AAQS
- Kobayashi Pharmaceutical Co Employees
- Kobayashi Pharmaceutical Co ROE
- Kobayashi Pharmaceutical Co ROA
- Kobayashi Pharmaceutical Co ROCE
